Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Twist Bioscience Corporation
  6. News
  7. Summary
    TWST   US90184D1000

TWIST BIOSCIENCE CORPORATION

(TWST)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Evercore ISI Adjusts Twist Bioscience PT to $98 From $110, Maintains In Line Rating

11/23/2021 | 11:36am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2021
All news about TWIST BIOSCIENCE CORPORATION
05/18Twist Bioscience to Present at the 2022 UBS Global Healthcare Conference
BU
05/12Certain Common Stock of Twist Bioscience Corporation are subject to a Lock-Up Agreement..
CI
05/12Certain Restricted Stock Units of Twist Bioscience Corporation are subject to a Lock-Up..
CI
05/12Certain Stock options of Twist Bioscience Corporation are subject to a Lock-Up Agreemen..
CI
05/11Miroculus, Inc. Optimizes Automated Next Generation Sequencing Library Preparation with..
CI
05/10Twist Bioscience Announces Participation in SRC Panel at the 2022 MRS Spring Meeting an..
BU
05/09Twist Bioscience Signs Research Collaboration, Exclusive Option License Deal With Astel..
MT
05/09JPMorgan Adjusts Price Target for Twist Bioscience to $30 From $65, Maintains Underweig..
MT
05/09Barclays Lowers Twist Bioscience's Price Target to $40 From $60, Maintains Overweight R..
MT
05/09Twist Bioscience Enters into Research, Exclusive Option and License Agreement with Aste..
BU
More news
Analyst Recommendations on TWIST BIOSCIENCE CORPORATION
More recommendations
Financials (USD)
Sales 2022 196 M - -
Net income 2022 -253 M - -
Net cash 2022 229 M - -
P/E ratio 2022 -7,25x
Yield 2022 -
Capitalization 1 929 M 1 929 M -
EV / Sales 2022 8,65x
EV / Sales 2023 6,93x
Nbr of Employees 652
Free-Float 91,4%
Chart TWIST BIOSCIENCE CORPORATION
Duration : Period :
Twist Bioscience Corporation Technical Analysis Chart | TWST | US90184D1000 | MarketScreener
Technical analysis trends TWIST BIOSCIENCE CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 34,28 $
Average target price 40,50 $
Spread / Average Target 18,1%
EPS Revisions
Managers and Directors
Emily Marine Leproust Chairman, President & Chief Executive Officer
James M. Thorburn Chief Financial Officer
Aaron K. Sato Chief Scientific Officer
Siyuan Chen Chief Technology Officer
Nimisha Srivastava Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
TWIST BIOSCIENCE CORPORATION-55.70%1 929
CSL LIMITED-6.06%91 946
SAMSUNG BIOLOGICS CO.,LTD.-11.85%44 385
BIOGEN INC.-18.43%28 662
WUXI BIOLOGICS (CAYMAN) INC.-42.79%28 457
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.-26.31%22 129